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Abstract
Predicting interactions among heterogenous
graph structured data has numerous applications
such as knowledge graph completion, recom-
mendation systems and drug discovery. Often
times, the links to be predicted belong to rare
types such as the case in repurposing drugs for
novel diseases. This motivates the task of few-
shot link prediction. Typically, GCNs are ill-
equipped in learning such rare link types since
the relation embedding is not learned in an in-
ductive fashion. This paper proposes an induc-
tive RGCN for learning informative relation em-
beddings even in the few-shot learning regime.
The proposed inductive model significantly out-
performs the RGCN and state-of-the-art KGE
models in few-shot learning tasks. Furthermore,
we apply our method on the drug-repurposing
knowledge graph (DRKG) for discovering drugs
for Covid-19. We pose the drug discovery task
as link prediction and learn embeddings for the
biological entities that partake in the DRKG. Our
initial results corroborate that several drugs used
in clinical trials were identified as possible drug
candidates. The method in this paper are imple-
mented using the efficient deep graph learning
(DGL) (Wang et al., 2019).
1. Introduction
The timeline of the Covid-19 pandemic showcases the dire
need for fast development of effective treatments for new
diseases. Drug-repurposing is a drug discovery strategy
from existing drugs that significantly shortens the time
and reduces the cost compared to de novo drug discov-
ery (Sertkaya et al., 2014; Avorn et al., 2015; Setoain et al.,
2015). Drug-repurposing leverages the fact that common
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molecular pathways contribute to different diseases and
hence some drugs may be reused (Ashburn & Thor, 2004).
Drug-repurposing relies on identifying novel interactions
among biological entities like genes and compounds and
can be posed as a link prediction task over a biological net-
work. Several machine learning approaches have been de-
veloped for addressing the drug-repurposingtask for Covid-
19; see e.g. (Gramatica et al., 2014; Zhou et al., 2020;
Udrescu et al., 2016; Ioannidis et al., 2020). Towards as-
sisting such machine learning techniques (Ioannidis et al.,
2020) created a comprehensive biological knowledge graph
relating genes, compounds, diseases, biological processes,
side effects and symptoms termed Drug Repurposing
Knowledge Graph (DRKG).
However, for novel diseases like Covid-19 only a few in-
teractions are available among viral proteins and possible
chemical compounds that may inhibit the related genes.
This motivates the framework of few-shot link prediction,
where a certain edge type is rare and the model is called to
make predictions on the particular edge type.
1.1. Related works
Link prediction has been addressed by several works in the
context of knowledge-graph (KG) completion. These mod-
els rely on embedding the nodes and edges of the KG to
a vector space and then train by maximizing the score for
existing edges in the KGs; see e.g., (Wang et al., 2017a).
An efficient implementation of these models in DGL is pre-
sented in (Zheng et al., 2020). Nevertheless, these KGE
models do not naturally generalize in the few-shot scenario,
where only a few edges are available for a rare edge type,
which challenges learning the relation embedding. This
was addressed in (Chen et al., 2019), where a meta-learning
model is proposed to learn the relation embeddings in an
inductive fashion. However, this inductive-relation KGE
model require a specialized training scheme, can not learn
inductive node embeddings, and can not incorporate node
features if available.
Graph convolutional networks learn embeddings for nodes
and edges in the graph by applying a sequence of nonlin-
ear operations parametrized by the graph adjacency matrix
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and utilize node and edge features (Kipf & Welling, 2017;
Schlichtkrull et al., 2018). An inductive implementation
of these models allows for learning node embeddings in
an inductive fashion (Hamilton et al., 2017). The RGCN
model (Schlichtkrull et al., 2018) has been successful in
link prediction, where the RGCN is supervised by KGE
models (Wang et al., 2017a). However, these GCN models
for link prediction inherit the limitation of the KGEmodels,
and are challenged in learning relation embeddings for rare
edges types.
1.2. Contributions
This paper addresses the aforementioned limitation of GCN
models by introducing a novel inductive-RGCN that learns
the relation and the node embeddings in an inductive fash-
ion. The proposed I-RGCN naturally addresses the few-
shot link prediction and outperforms competing state-of-
the-art models. I-RGCN is also tested in the DRKG for
Covid-19 drug-repurposing. The drug discovery task is nat-
urally formulated in a few-shot learning setting. The pre-
liminary results indicate that several drugs used in clinical
trials are discovered as possible drug candidates. While this
study, by no means recommends specific drugs, it demon-
strates a powerful deep learning methodology to prioritize
existing drugs for further investigation, which holds the po-
tential of accelerating therapeutic development for COVID-
19.
2. Few-shot link prediction formulation
Consider the heterogeneous graph with T node types and
R relation types defined as G := {{Vt}Tt=1, {Er}
R
r=1}. The
tth node type is defined as Vt := {vtn}
Nt
n=1 and may repre-
sent Genes or Chemical compounds in the DRKG. The rth
relation type holds all interactions of a certain type among
N t and N t
′
Er := {(vtn, v
t′
n ) ∈ N
t × N t
′
} and may rep-
resent that a chemical compound inhibits a gene or that a
disease is treated by a chemical compound.
Consider also that each node nt is associated with a
F × 1 feature vector xnt . This feature may represent
an embedding of the protein sequence associated with a
gene (Wang et al., 2017b). In KGs some node types may
not have features for these we use an embedding layer to
represent their features.
Few shot link prediction. Given R − 1 sets of edges
{Er}
R−1
r=1 , a nodal attribute vector xnt per node nt, and a
small set of links in the few-shot relation ER with |ER| ≤
K , the few-shot link prediction amounts to inferring the
missing links of the rare type R. In the DRKG, this few-
shot relation is for example coronavirus treatment.
3. Learning inductive embedding for GNNs
The relational GCN (RGCN) (Schlichtkrull et al., 2018)
extends the graph convolution operation (Kipf & Welling,
2017) to heterogenous graphs. An RGCN model is com-
prised by a sequence of RGCN layers. The lth layer com-
putes the nth node representation h
(l+1)
n as follows
h
(l+1)
n := σ


R∑
r=1
∑
n′∈N r
n
h
(l)
n′W
(l)
r

 (1)
where N rn is the neighborhood of node n under relation r,
σ the rectified linear unit non linear function, and W
(l)
r is
a learnable matrix associated with the rth relation. Essen-
tially, the output of the RGCN layer for node n is a nonlin-
ear combination of the hidden representations of neighbor-
ing nodes weighted based on the relation type. The node
features are the input of the first layer in the model i.e.
h
(0)
n = xn, where xn is the node feature for node n. For
node types without features we use an embedding layer that
takes as input an one-hot encoding of the node id.
The RGCN model in this paper is supervised by a DistMult
model (Yang et al., 2014) for link prediction. The loss func-
tion
min
∑
nt,r,nt′∈D
+∪D−
log(1 + exp(−y × h⊤ntdiag(hr)hnt′ ))
(2)
where h⊤ denotes the transpose of a matrix, diag(r) de-
notes a diagonal matrix with r on its diagonal, hnt , hr,
hn
t′
are the embedding of the head entity nt, relation r
and the tail entity nt′ , respectively and D
+ and D− are the
positive and negative sets of triplets and y = 1 if the triplet
corresponds to a positive example and −1 otherwise. The
scalar represented by h⊤diag(hr)t denotes the score of
triplet (h, r, t) as given by the DistMult model (Yang et al.,
2014). The entity embeddings are obtained by the fi-
nal layer of the RGCN. The relation type embedding are
trained directly from (2).
Such a model (2) is vulnerable when only few training
edges are available for a certain relation type. The small
number of edges will challenge the learning of the embed-
ding vector r for the rare relation.
3.1. Inductive RGCN
Certain relation-types may be rare in the training set of
links and require a specialized architecture. To address
such a few-shot scenario, we introduce a MLP to learn
the relation embeddings. Consider the node embeddings
{hnt} and {hnt′} extracted from the ultimate layer of the
RGCN model where nt ∈ Vt and nt′ ∈ Vt′ . The proposed
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Table 1. Statistics of datasets.
Nodes Edges Relation types
IMDb
movie : 4,278
director : 2,081
actor : 5,257
17,106 12
DBLP
author : 4,057
paper : 14,328
term : 7,723
venue : 20
119,783 12
MLP learns an embedding for the rth relation as follows
hr :=
1
|Er|
∑
(nt,nt′ )∈Er
σ(W1σ(W2(hnt ||hnt′ )) (3)
where || denotes the vector concatenation. Note that the re-
lation embedding hr is calculated as a nonlinear function
of the node embedding for all node pairs (nt, nt′) partici-
pating to a certain relation type (nt, nt′) ∈ Er. This allows
the I-RGCN to learn relation embeddings in an inductive
fashion. This model is supervised by the following loss
LFSLP := log(1 + exp(−y × h
⊤
nt
diag(hr)hn
t′
)) (4)
where h⊤ntdiag(hr)hnt′ denotes the triple score and y is−1
for the negative triples and 1 stands for the positive ones.
We create negative triples by fixing the head node of a pos-
itive triple and randomly selecting a tail node of the same
type as the original tail node. Differently from (2), the rela-
tion embedding hr is learned in an inductive fashion from
the participating node pairs (nt, nt′ ). Hence, upon learning
the MLP parametersW1,W2 the relation embedding will
be computed with a forward pass. This obviates the few-
shot learning hurdle and enables the model to generalize to
rare or even unseen relations.
4. Experiments
4.1. Few shot link prediction
Baselines.We consider the state-of-the-artKGEmodels Ro-
tatE (Sun et al., 2019), ComplEx (Trouillon et al., 2016),
and the RGCN model (Schlichtkrull et al., 2018) as base-
lines for comparison. The parameters of these methods
have been optimized via cross validation. We use the
IMDB and DBLP datasets (Fu et al., 2020) detailed in Ta-
ble 1. The total number of edges in the few-shot relation
are 1559 for the IMDB and 3534 for the DBLP. In the ex-
periments. we train with only K links from the few-shot
relation and all the links from the other relations and test on
the rest edges of the few-shot relation, which are |ER| −K .
The nodes in the IMDB and DBLP graphs are associated
with feature vectors. Further, information on the datasets is
included in the Appendix.
Tables 2 and 3 report the MRR, Hit-1 and Hit-10 scores of
the baseline methods along with the inductive RGCN and
the RGCN in the task of few-shot link prediction for the
IMDB and DBLP datasets respectively. The I-RGCN sig-
nificantly outperforms the alternative methods in the task of
few-shot link prediction. Specifically, for K=10 the MRR
of the inductive method is one order of magnitude greater.
This corroborates the advantage of the inductive relation
learning for the few-shot learning task. As the number of
training edges increases at K=1000, it is observed that the
RGCN performance approaches the performance of the I-
RGCN. This suggests that the I-RGCN method performs
well also in non few-shot learning tasks. The worse per-
formance of KGE models is explained since these do not
account for node features and do learn inductive relation
embeddings.
To further validate the performance of the I-RGCN we con-
duct a general link prediction evaluation by splitting the
links in training, validation, and testing at random irrespec-
tive of their relation type. The results for different percent-
ages of training links are reported in Table 4. I-RGCN
outperforms even in this training scenario the RGCN and
KGEs baselines, which further corroborates the efficiency
of the model.
4.2. Drug-repurposing via I-RGCN
For this experiment we will utilize the drug-repurposing
knowledge graph (DRKG) constructed in (Ioannidis et al.,
2020). The DRKG collects interactions from a collection of
biological databases such as Drugbank (DS et al., 2017b),
GNBR (Percha & Altman, 2018), Hetionet (DS et al.,
2017a), STRING (D et al., 2019), IntAct (Orchard et al.,
2014) and DGIdb (Cotto et al., 2017).
Drug-repurposing aims at discovering the most effective ex-
isting drugs to treat a certain disease. Drug-repurposing
can be formulated as predicting direct links in the DRKG
such as predicting whether a drug treats a disease or as pre-
dicting whether a compound inhibits a certain gene which
is related to the target disease. Drug-repurposing can be
viewed as a few-shot link prediction task since only a few
edges are available related to novel diseases in the DRKG.
We use corona-virus related diseases, including SARS,
MERS and SARS-COV2, as target diseases representing
Covid-19 as their functionality is similar. We aim at pre-
dicting links among gene entities associated with the target
disease and drug entities.We select FDA-approved drugs in
Drugbank as candidates, while we exclude for simplicity
drugs with molecule weight less than 250 daltons, as many
of certain drugs are actually health drugs. This amounts to
8104 candidate drugs.
We also obtain 442 Covid-19 related genes from the re-
lations extracted from (Gordon et al., 2020; Zhou et al.,
2020). Similarly, we obtain the node embeddings for the
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Table 2. Experiment results (%) on the IMDb dataset for k-shot link prediction.
MRR Hit 1 Hit 10
K ComplEx RotatE RGCN I-RGCN ComplEx RotatE RGCN I-RGCN ComplEx RotatE RGCN I-RGCN
10 6.88 11.80 1.32 33.56 1.75 6.74 0.13 25.32 14.25 18.35 1.07 53.55
50 8.48 12.56 15.26 53.24 3.34 7.76 7.42 45.14 15.70 19.12 28.88 69.32
100 8.61 12.57 18.78 53.63 3.44 7.86 9.59 40.27 15.71 18.40 36.84 77.38
1000 68.37 70.09 95.23 96.06 65.48 67.52 91.72 93.56 72.23 73.50 99.72 99.81
Table 3. Experiment results (%) on the DBLP dataset for k-shot link prediction.
MRR Hit 1 Hit 10
K ComplEx RotatE RGCN I-RGCN ComplEx RotatE RGCN I-RGCN ComplEx RotatE RGCN I-RGCN
10 5.97 7.41 7.42 27.95 1.37 2.13 2.95 13.78 11.81 15.36 12.51 60.51
50 6.32 7.87 17.25 83.42 1.55 2.26 10.95 72.54 12.59 16.64 26.84 96.82
100 7.24 10.66 32.45 90.00 1.99 04.43 23.46 85.27 14.96 20.92 49.85 97.61
1000 36.56 46.51 91.34 96.82 30.62 39.83 86.43 94.41 46.45 59.27 98.59 99.81
Table 4. Experiment results (%) on the IMDb dataset for link prediction.
Metrics MRR Hit 1 Hit 10
Training links ComplEx RotatE RGCN I-RGCN ComplEx RotatE RGCN I-RGCN ComplEx RotatE RGCN I-RGCN
95% 94.15 93.97 93.38 95.12 93.75 93.48 89.31 92.75 94.74 94.56 99.29 98.24
90% 88.87 88.89 89.30 93.98 88.25 87.87 83.45 91.52 89.74 90.35 97.66 98.12
80% 78.55 78.90 83.46 90.03 77.45 76.83 76.59 86.70 79.96 81.94 94.72 95.93
70% 69.59 69.56 82.73 87.00 67.98 66.73 76.09 82.95 71.89 73.49 93.76 94.07
60% 60.40 60.90 78.16 81.53 58.49 57.60 70.63 77.01 62.92 65.57 91.14 90.27
gene and drugs, and the embeddings for the corresponding
relations. Next, we score all triples and rank them per tar-
get gene. This way we obtain 442 ranked lists of drugs.
Finally, to assess whether our prediction is in par with the
drugs used for treatment, we check the overlap among the
top 100 predicted drugs and the drugs used in clinical trials
per gene. We used 32 clinical trial drugs for Covid-19 to
validate our predictions1. Table 5 lists the clinical drugs in-
cluded in the top-100 predicted drugs across all the genes
with their corresponding number of hits for the RGCN and
I-RGCN. It can be observed, that several of the widely used
drugs in clinical trials appear high on the predicted list, and
that I-RGCN shows a higher hit rate than RGCN. Hence,
the inductive relation prediction module is more appriopri-
ate in predicting links when information about the nodes is
limited, such as is the case with the novel Covid-19 disease
node.
5. Conclusion
In this paper we develop a novel I-RGCN that learns in-
ductive relation embeddings and can be applied for few-
shot link prediction and drug repurposing. I-RGCN con-
sistently outperforms baseline models in the IMDB and
DBLP datasets for few-shot link prediciton. We also for-
mulate the Covid-19 drug-repurposing task as a link pre-
diction over the DRKG. I-RGCN successfully identifies a
subset of clinical trial drugs for Covid-19 and can be used
1The clinical trial drugs were collected from
http://www.covid19-trails.com/
Table 5. Drug inhibits gene scores for Covid-19. Note that a ran-
dom classifier will result to approximately 5.3 per drug. This sug-
gests that the reported predictions are significantly better than ran-
dom.
I-RGCN RGCN
Drug name # hits Drug name # hits
Dexamethasone 240 Chloroquine 69
Ribavirin 142 Colchicine 41
Colchicine 128 Tetrandrine 40
Chloroquine 115 Oseltamivir 37
Methylprednisolone 86 Azithromycin 36
Tofacitinib 75 Tofacitinib 33
Thalidomide 70 Ribavirin 32
Losartan 64 Methylprednisolone 30
Hydroxychloroquine 48 Deferoxamine 30
Oseltamivir 46 Thalidomide 25
Deferoxamine 34 Dexamethasone 24
Ruxolitinib 23 Bevacizumab 21
Azithromycin 23 Hydroxychloroquine 19
Nivolumab 11 Losartan 19
Tradipitant 11 Ruxolitinib 13
Bevacizumab 10 Eculizumab 12
Eculizumab 7 Tocilizumab 11
Baricitinib 6 Anakinra 11
Sarilumab 6 Sarilumab 8
Tetrandrine 6 Nivolumab 6
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to assist researchers and prioritize existing drugs for further
investigation in the Covid-19 treatment.
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A. Datasets
We use the IMDB and DBLP datasets (Fu et al., 2020) de-
tailed in Table 1, where the third column denotes the to-
tal size of edges in the few-shot relation that is |ER|. The
nodes in the IMDB and DBLP graphs are associated with
feature vectors. The original datasets in (Fu et al., 2020)
are used for node classification. We adapt the datasets and
create new edge types, where the edges are parametrized
by the label of the associated nodes. For example, the
edge type (director, directed, movie) becomes (director,
directed drama, movie) if the associated movie is in the
drama genre, and the same transformation undergoes the
(actor, played, movie) relation. Since, there are 3 labels for
movies, this way the original 4 edge types become 12. The
same transformation happens in the DBLP dataset.
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